SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000947871-18-000734
Filing Date
2018-09-07
Accepted
2018-09-07 16:58:13
Documents
2
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VI LLCORBIMED ISRAEL GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 ss106348_sc13da.htm SC 13D/A 169883
2 JOINT FILING AGREEMENT ss106348_ex9901.htm EX-99.1 29615
  Complete submission text file 0000947871-18-000734.txt   201073
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 5 OPPENHEIMER STREET REHOVOT L3 76701
Business Address 5 OPPENHEIMER STREET REHOVOT L3 76701 (925) 272-4991
SteadyMed Ltd. (Subject) CIK: 0001619087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88774 | Film No.: 181060682
SIC: 2834 Pharmaceutical Preparations